Home valeant
 

Keywords :   


Tag: valeant

Valeant to expand in Mid-East, North Africa with $800-million purchase of Amoun

2015-07-17 15:29:22| Biotech - Topix.net

Valeant Pharmaceuticals International, Inc. says it will buy a major Egyptian pharmaceutical company for about US$800 million as a platform for further expansion in the Middle East and North Africa. The deal will include Amoun's manufacturing plant, which Valeant says is one of the largest and most modern in the region.

Tags: north purchase africa expand

 

Valeant Pharmaceuticals: Not Your Average Pharma Stock

2015-06-04 13:48:43| Biotech - Topix.net

Valeant Pharmaceuticals is a multinational specialty pharmaceutical company that develops and markets prescription and non-prescription products. The company was founded in 1983 and is headquartered in Laval, Quebec, Canada.

Tags: average stock pharma pharmaceuticals

 
 

Big name investors take sides on Ackman bet on Valeant: filings

2015-05-16 18:10:24| Biotech - Topix.net

With its stock up 56 percent since January, the Canadian company is giving new and existing investors plenty to cheer about. In the last 52 weeks, it has risen 80 percent, outperforming both the S&P 500 Index and the Pharmaceuticals sub-index.

Tags: big sides bet investors

 

Valeant raises outlook after completing purchase of Salix

2015-04-30 09:04:09| Biotech - Topix.net

" Valeant Pharmaceuticals International Inc. said Wednesday it turned a profit in the first quarter, and the Canadian drugmaker raised its forecasts for the year after completing more acquisitions. The company reported a profit of $73.7 million, or 21 cents per share, after it lost $22.6 million, or 7 cents per share, a year ago.

Tags: purchase outlook completing raises

 

Valeant reports stronger Q1 results, issues bullish outlook for Q2 and 2015

2015-04-29 20:49:15| Biotech - Topix.net

Valeant Pharmaceuticals International Inc. has issued first quarter results that beat analyst estimates and boosted its 2015 estimates to account for about US$1 billion of additional revenue from Salix Pharmaceuticals. The Quebec-based company conducted a bidding war for Salix during the first quarter and closed the US$11.1-billion deal on April 1, which marked the beginning of its second quarter.

Tags: results issues reports outlook

 

Sites : [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] next »